1. 1239 Microcosting evaluation of prognostic/predictive biomarkers performed in a large French prospective cohort of non previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort. (September 2015) Authors: Loubiere, S.; Wislez, M.; Beau-faller, M.; Nanni-metellus, I.; Garcia, S.; Chenard, M.P.; Ghnassia, J.P.; Lacave, R.; Antoine, M.; Sobol, H.; Paciencia-gros, M.; Escande, F.; Copin, M.C.; Morin, F.; Missy, P.; Cadranel, J.; Barlesi, F.; Auquier, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS). (January 2017) Authors: Faivre-Finn, C.; Snee, M.; Ashcroft, L.; Appel, W.; Barlesi, F.; Bhatnagar, A.; Bezjak, A.; Cardenal, F.; Fournel, P.; Harden, S.; Le Pechoux, C.; McMenemin, R.; Mohammed, N.; O'Brien, M.; Pantarotto, J.; Surmont, V.; Van Meerbeeck, J.; Woll, P.; Lorigan, P.; Blackhall, F. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3010 Phase, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): Subgroup analyses and patient reported outcomes (PROs). (September 2015) Authors: Horn, L.; Brahmer, J.; Reck, M.; Borghaei, H.; Spigel, D.R.; Steins, M.; Ready, N.E.; Chow, L.Q.; Vokes, E.E.; Felip, E.; Holgado, E.; Barlesi, F.; Kohlhäufl, M.J.; Burgio, M.A.; Fayette, J.; Gettinger, S.N.; Harbison, C.T.; Li, A.; Finckenstein, F.G.; Paz-Ares, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3062 Ceritinib following crizotinib in ALK-positive (+) advanced NSCLC patients (pts): Results from the French Temporary Authorization for Use (ATU) experience. (September 2015) Authors: Cadranel, J.; Cortot, A.; Lena, H.; Mennecier, B.; Do, P.; Dansin, E.; Mazieres, J.; Chouaid, C.; Perol, M.; Barlesi, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3091 Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results. (September 2015) Authors: Juhasz, E.; Ramalingam, S.; Blais, N.; Mazieres, J.; Reck, M.; Jones, M.; Urban, L.; Orlov, S.; Barlesi, F.; Kio, E.; Keilholz, U.; Qian, J.; Qin, Q.; Ansell, P.; Dziubinski, J.; Nickner, C.; McKee, M.; Giranda, V.; Gorbunova, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 3093 Veliparib with carboplatin and paclitaxel: factors predictive of favorable outcomes in NSCLC. (September 2015) Authors: Reck, M.; Ramalingam, S.; Blais, N.; Mazieres, J.; Jones, M.; Juhasz, E.; Urban, L.; Orlov, S.; Barlesi, F.; Kio, E.; Keilholz, U.; Qian, J.; Qin, Q.; Dziubinski, J.; Nickner, C.; Ansell, P.; McKee, M.; Giranda, V.; Gorbunova, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 3100 Phase Ib/II study of the pan-cyclin-dependent kinase (CDK) inhibitor roniciclib (BAY 1000394) in combination with chemotherapy as first-line therapy in subjects with extensive disease small cell lung cancer (ED-SCLC). (September 2015) Authors: Cho, B.C.; Dy, G.K.; Govindan, R.; Kim, D.W.; Pennell, N.A.; Zalcman, G.; Besse, B.; Nogai, H.; Rajagopalan, P.; Ocker, M.; Barlesi, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 3101 Updated efficacy and safety results from a global phase 2, open-label, single-arm study (NP28673) of alectinib in crizotinib-refractory ALK+ non-small-cell lung cancer (NSCLC). (September 2015) Authors: Barlesi, F.; Dingemans, A.M.C.; Ou, I.; Ahn, J.S.; Petris, L.D.; Kim, D.W.; Yang, J.C.H.; Hughes, B.; Lena, H.; Moro-Sibilot, D.; Bearz, A.; Viteri, S.; Mekhail, T.; Spira, A.; Zeaiter, A.; Bordogna, W.; Sturm, C.; Golding, S.; Morcos, P.N.; Govindan, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 3128 EGFR, ALK, KRAS prognostic value in a large French prospective cohort of non-previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort. (September 2015) Authors: Cadranel, J.; Quoix, E.; Duruisseaux, M.; Friard, S.; Fabre, E.; Daniel, C.; Westeel, V.; Madroszyk, A.; Lena, H.; Merle, P.; Mazieres, J.; Dansin, E.; Scherpereel, A.; Hiret, S.; Coudert, B.; Souquet, P.J.; Missy, P.; Morin, F.; Zalcman, G.; Barlesi, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 3MO Comprehensive biomarkers (BMS) analysis to predict efficacy of PD1/L1 immune checkpoint inhibitors (ICIs) in combination with chemotherapy: A subgroup analysis of the precision immuno-oncology for advanced non-small cell lung cancer (pioneer) trial. (December 2022) Authors: Barlesi, F.; Greillier, L.; Monville, F.; Audigier Valette, C.; Martinez, S.; Cloarec, N.; Van Hulst, S.; Odier, L.; Vely, F.; Juquel, L.; Arnaud, L.; Bokobza, S.; Hamimed, M.; Karlsen, M.; Dufosse, P.; Pouchin, A.; Ghezali, L.; Le Ray, M.; Fieschi-Meric, J.; Benzekry, S. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗